Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Issues
2013
July 2013, Vol 4, No 6
July 2013, Vol 4, No 6
Patient Navigators Enhance Colonoscopy Screening Rates and Save Money in the Long Run
By
Caroline Helwick
Patient Navigation
,
Policies & Guidelines
July 2013, Vol 4, No 6
>Orlando, FL—The use of patient navigators can reduce racial disparities in colorectal cancer (CRC) screening and can potentially reduce the mortality rates—and do both cost-effectively, according to studies presented at Digestive Disease Week 2013.
Read Article
Healthcare Reform and End-of-Life Care Myths versus Reality
By
Caroline Helwick
End-of-Life Care
,
Policies & Guidelines
July 2013, Vol 4, No 6
Hollywood, FL—End-of-life issues have advanced in a positive direction since the so-called death panel controversy of 2009, but health plans still need to promote these discussions, said J. Russell Hoverman, MD, PhD, Vice President, Quality Programs, Texas Oncology, at the Third Annual Conference of the Association for Value-Based Cancer Care.
Read Article
340B Program
Meet the Experts
July 2013, Vol 4, No 6
At the Third Annual Conference of the Association for Value-Based Cancer Care, several Meet the Experts roundtable discussions addressed the hottest topics in oncology.
Read Article
A PBM Perspective on Biosimilars
By
Caroline Helwick
Biosimilars
July 2013, Vol 4, No 6
Hollywood, FL—Pharmacy benefit managers (PBMs) will soon have the new challenge of dealing with the confusion of biosimilars, according to Douglas S. Burgoyne, PharmD, President and Managing Partner, VRx Pharmacy Services, Salt Lake City, UT, a full-service PBM company that provides medication therapy management, case management, and other clinical services to employer group waiver plans and commercial payers.
Read Article
Combination Therapy with Nivolumab and Ipilimumab Superior to Monotherapy in Advanced Melanoma
In the Literature
July 2013, Vol 4, No 6
A new study investigated whether combined immune blockade with ipilimumab and nivolumab would increase survival in patients with advanced melanoma (Wolchok JD, et al.
N Engl J Med
. 2013;369:122-133).
Read Article
Neoadjuvant Lapatinib and Trastuzumab with Hormonal Therapy for HER2 Breast Cancer
In the Literature
July 2013, Vol 4, No 6
A new phase 2 clinical trial is one of the first to investigate the use of hormonal therapy without chemotherapy as a neoadjuvant strategy for patients with HER2-positive breast cancer (Rimawi MF, et al.
J Clin Oncol
. 2013;31:1726-1731).
Read Article
New Drug Application for Ibrutinib Submitted to FDA for B-Cell Malignancies
FDA Approvals, News & Updates
July 2013, Vol 4, No 6
Read Article
Gilotrif Approved for Metastatic Lung Cancer with EGFR Mutations, Concurrent with a Companion Diagnostic Test
FDA Approvals, News & Updates
July 2013, Vol 4, No 6
The US Food and Drug Administration (FDA) approved the tyrosine kinase inhibitor afatinib (Gilotrif; Boehringer Ingelheim Pharmaceuticals) for the treatment of patients with metastatic non–small-cell lung cancer (NSCLC) who have the epidermal growth factor receptor (EGFR) gene mutations exon 19 deletions or exon 21 L858R substitution.
Read Article
Brown Bagging versus White Bagging
Meet the Experts
July 2013, Vol 4, No 6
At the Third Annual Conference of the Association for Value-Based Cancer Care, several Meet the Experts roundtable discussions addressed the hottest topics in oncology. James T. Kenney, Jr, RPh, MBA, Pharmacy Operations Manager at Harvard Pilgrim, and Douglas S. Burgoyne, PharmD, President and Managing Partner, VRx Pharmacy Services, discussed the topic of brown and white bagging at one of these sessions.
Read Article
Payers Must Step Up Their Utilization Management Programs
By
Caroline Helwick
July 2013, Vol 4, No 6
Hollywood, FL—With the Affordable Care Act about to be fully enacted, and growing concerns about managing oncology costs, health plans will put simple processes in place ahead of new drug approvals to more actively manage these medications, said James T. Kenney, Jr, RPh, MBA, Pharmacy Operations Manager, Harvard Pilgrim Health Care, Wellesley, MA, at the Third Annual Conference of the Association for Value-Based Cancer Care.
Read Article
Page 1 of 3
1
2
3
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma